CN105456178A - Active bio-enzyme conditioning extract - Google Patents
Active bio-enzyme conditioning extract Download PDFInfo
- Publication number
- CN105456178A CN105456178A CN201510942356.1A CN201510942356A CN105456178A CN 105456178 A CN105456178 A CN 105456178A CN 201510942356 A CN201510942356 A CN 201510942356A CN 105456178 A CN105456178 A CN 105456178A
- Authority
- CN
- China
- Prior art keywords
- extract
- enzyme
- lactobacillus
- bacillus
- lysozyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses active bio-enzyme conditioning extract. The active bio-enzyme conditioning extract comprises, by mass, 14%-16% of lactobacillus acidophilus, 1.35%-15.5% of bifidobacterium longum, 12.5%-14.5% of lactobacillus casei, 11.8%-13.8% of oviform bifidobacteria, 11%-13% of lactobacillus jensenii, 8%-10% of Raman lactobacillus, 6.5%-8.5% of bifidobacterium thermophilum, 1.5%-2.5% of pullulan, 1.5%-2.5% of bacillus subtilis fibrinolytic enzyme, 1.5%-2.5% of lysozyme, 1.5%-2.5% of lysozyme beta-glucan, 1.5%-2.5% of plankton extract, 1.3%-1.7% of bletilla striata root extract, 0.8%-1.2% of scutellaria baicalensis extract, 1%-1.4% of centella asiatica extract, 0.4%-0.6% of licorice extract, 0.7%-0.9% of polygonum cuspidatum extract and 0.3%-0.5% of matricaria extract. The active bio-enzyme conditioning extract is an active bio-enzyme and plant ferment formula developed specially for people with acne-prone and sensitive skin, and is capable of fundamentally improving sensitive, dark and rough skin, removing acne, and recovering white and bright skin.
Description
Technical field
The present invention relates to a kind of cosmetics, one can Eradicates pox, the makeup of conditioning skin, specifically a kind of active biological enzyme conditioning stock solution.
Background technology
Comedo, acne, skin sore are medically referred to as acne, are a kind of common sebaceous gland chronic diseases, and the factors such as the generation of acne is main and hypersteatosis, pilosebaceous duct block, bacteriological infection and inflammatory reaction are closely related.After adolescing, in human body, the level of androgen particularly testosterone raises rapidly, promotes that sebaceous gland is grown and produces a large amount of sebum.The dyskeratosis of pilosebaceous duct causes catheter blockage, dyssebacia simultaneously, forms horn plug and micropowder thorn.Multiple-microorganism especially propionibacterium acnes amount reproduction in hair follicle, the lipase decomposition sebum that propionibacterium acnes produces generates free fatty, chemotactic inflammatory cell and medium simultaneously, final induction also exacerbate inflammation reaction.
Comedo routine collaborative treatment of Chinese and western medicines, is generally oral medicine, little external, and treatment speed is slow, and effect is general, also can develop immunity to drugs.Existing Eradicates pox product mostly is pure chemistry synthesis, has stimulation to skin, stays scar serious, there will be allergic phenomena after some uses after Eradicates pox, the most important thing is to be difficult to fundamentally address this problem.
Summary of the invention
The object of the present invention is to provide a kind of new formula, a kind of active biological enzyme conditioning stock solution.
A kind of active biological enzyme conditioning of the present invention stock solution, consists of the following composition: bacillus acidophilus 14% ~ 16% in mass ratio, long qi bacillus 13.5% ~ 15.5%, lactobacillus casei 12.5% ~ 14.5%, avette bacillus bifidus 11.8% ~ 13.8%, Lactobacillus Jensenii 11% ~ 13%, Raman lactobacillus 8% ~ 10%, bifidobacterium thermophilum 6.5% ~ 8.5%, sprout short stalk enzyme polysaccharide 1.5% ~ 2.5%, bacillus subtilis enzyme 1.5% ~ 2.5%, lysozyme 1.5% ~ 2.5%, lysozyme beta glucan 1.5% ~ 2.5%, plankton (TETRASELMISSUECICA) extract 1.5% ~ 2.5%, the Pseudobulbus Bletillae (Rhizoma Bletillae) (BLETILLASTRIATA) root extract 1.3% ~ 1.7%, Radix Scutellariae (SCUTELLARIABAICALENSIS) extract 0.8% ~ 1.2%, Herba Centellae (CENTELLAASIATICA) extract 1% ~ 1.4%, Radix Glycyrrhizae (GLYCYRRHIZAURALENSIS) extract 0.4% ~ 0.6%, Rhizoma Polygoni Cuspidati (POLYGONUMCUSPIDATUM) extract 0.7% ~ 0.9%, Flos Matricariae chamomillae (CHAMOMILLARECUTITA) extract 0.3% ~ 0.5%.
In the present invention, important composition pharmacology is as follows:
Bacillus acidophilus and epithelial cell have been bonded biological barrier mutually, closely, stop the field planting of pathogenic bacterium and invasion, can delay body aging, can the immunity of anticancer and enhancing body, have the effect reducing serum cholesterol.
Lactobacillus casei has antibacterial and effect that is antiinflammatory.
Lysozyme has antibacterial, antiviral and antiinflammation, and can improve the immunity of human body, itself is a kind of native protein in addition, can be absorbed by the body, avirulence simultaneously, can not remain at human body.
Lysozyme beta glucan is mainly used in the cell wall decomposing cell, plays significant synergism to degradative fungi cell wall.
The Pseudobulbus Bletillae (Rhizoma Bletillae) is Pseudobulbus Bletillae (Rhizoma Bletillae) again, another name: Lian Jicao, Gan Gen, give free of charge, indocalamus orchid, Zhu Lan, Rhizoma Bletillae, purple a species of orchid, hundred large bamboo hats with a conical crown and broad brim, have astringing to arrest bleeding, effect of detumescence and promoting granulation.
Radix Scutellariae another name Chimonanthus salicifolius S.Y.Hu. root has antibacterial, antiviral, antifungic action.
Herba Centellae Herba Centellae is cold in nature, has the effect of heat clearing away, reducing swelling and alleviating pain, anti-inflammation.
Radix Glycyrrhizae has the pharmacological action of removing toxic substances, pain relieving, anticancer, spasmolytic.
Rhizoma Polygoni Cuspidati has the pharmacological action of analgesia sterilization.
Flos Matricariae chamomillae has the pharmacological action of antiinflammatory, spasmolytic.
The present invention aims at active biological enzyme and the plant fermentation essence formula of small pox and tender subject skin crowd development, and safety is gentle, effectively the multiple skin problem of conditioning.For pustular type small pox and the conditioning of acne small pox flesh orientation, coordinate natural plants maintenance composition, fundamentally improve skin sensitivity, dark yellow, coarse, desalination pox print, represent snow face and become clear.
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, be clearly and completely described the formula in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
In the embodiment of the present invention, a kind of active biological enzyme conditioning stock solution, concrete preparation process is:
Embodiment 1
Producing of a kind of active biological enzyme conditioning stock solution: get bacillus acidophilus 15g, long qi bacillus 14.5g, lactobacillus casei 13.5g, avette bacillus bifidus 12.8g, Lactobacillus Jensenii 12g, Raman lactobacillus 9g, bifidobacterium thermophilum 7.8g, sprout short stalk enzyme polysaccharide 2g, bacillus subtilis enzyme 2g, lysozyme 2g, wherein lysozyme beta glucan 2g, plankton (TETRASELMISSUECICA) extract 2g, the Pseudobulbus Bletillae (Rhizoma Bletillae) (BLETILLASTRIATA) root extract 1.5g, Radix Scutellariae (SCUTELLARIABAICALENSIS) extract 1g, Herba Centellae (CENTELLAASIATICA) extract 1.2g, Radix Glycyrrhizae (GLYCYRRHIZAURALENSIS) extract 0.5g, Rhizoma Polygoni Cuspidati (POLYGONUMCUSPIDATUM) extract 0.8g, Flos Matricariae chamomillae (CHAMOMILLARECUTITA) extract 0.4g stirs with clean puddler and is sealed in clean appearance ware, and deposit in the environment of less than 45 DEG C.
During use, first should clean face, then draw appropriate a kind of active biological enzyme conditioning stock solution with product dropper, be coated on face or be only coated on small pox place, a twice-daily, skin problem severe patient suitably increases coating number of times.
Embodiment 2
Producing of a kind of active biological enzyme conditioning stock solution: get bacillus acidophilus 14g, long qi bacillus 15.5g, lactobacillus casei 14.5g, avette bacillus bifidus 11.8g, Lactobacillus Jensenii 11g, Raman lactobacillus 10g, bifidobacterium thermophilum 8.5g, sprout short stalk enzyme polysaccharide 1.5g, bacillus subtilis enzyme 1.5g, lysozyme 2.5g, wherein lysozyme beta glucan 1.5g, plankton (TETRASELMISSUECICA) extract 1.5g, the Pseudobulbus Bletillae (Rhizoma Bletillae) (BLETILLASTRIATA) root extract 1.7g, Radix Scutellariae (SCUTELLARIABAICALENSIS) extract 1.2g, Herba Centellae (CENTELLAASIATICA) extract 1.4g, Radix Glycyrrhizae (GLYCYRRHIZAURALENSIS) extract 0.6g, Rhizoma Polygoni Cuspidati (POLYGONUMCUSPIDATUM) extract 0.9g, Flos Matricariae chamomillae (CHAMOMILLARECUTITA) extract 0.5g stirs with clean puddler and is sealed in clean appearance ware, and deposit in the environment of less than 45 DEG C.
The using method of embodiment 2 is identical with embodiment 1.
Embodiment 3
Producing of a kind of active biological enzyme conditioning stock solution: get bacillus acidophilus 16g, long qi bacillus 13.5g, lactobacillus casei 13g, avette bacillus bifidus 13.8g, Lactobacillus Jensenii 13g, Raman lactobacillus 8.2g, bifidobacterium thermophilum 6.5g, sprout short stalk enzyme polysaccharide 2.5g, bacillus subtilis enzyme 2.5g, lysozyme 1.5g, wherein lysozyme beta glucan 2.5g, plankton (TETRASELMISSUECICA) extract 2.5g, the Pseudobulbus Bletillae (Rhizoma Bletillae) (BLETILLASTRIATA) root extract 1.3g, Radix Scutellariae (SCUTELLARIABAICALENSIS) extract 0.8g, Herba Centellae (CENTELLAASIATICA) extract 1g, Radix Glycyrrhizae (GLYCYRRHIZAURALENSIS) extract 0.4g, Rhizoma Polygoni Cuspidati (POLYGONUMCUSPIDATUM) extract 0.7g, Flos Matricariae chamomillae (CHAMOMILLARECUTITA) extract 0.3g stirs with clean puddler and is sealed in clean appearance ware, and deposit in the environment of less than 45 DEG C.
The using method of embodiment 3 is identical with embodiment 1.
To those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and when not deviating from spirit of the present invention or basic feature, the present invention can be realized in other specific forms.Therefore, no matter from which point, all should embodiment be regarded as exemplary, and be nonrestrictive, scope of the present invention is limited by claims instead of above-mentioned explanation, and all changes be therefore intended in the implication of the equivalency by dropping on claim and scope are included in the present invention.
In addition, be to be understood that, although this description is described according to embodiment, but not each embodiment only comprises an independently technical scheme, this narrating mode of description is only for clarity sake, those skilled in the art should by description integrally, and the technical scheme in each embodiment also through appropriately combined, can form other embodiments that it will be appreciated by those skilled in the art that.
Claims (2)
1. an active biological enzyme conditioning stock solution, it is characterized in that by mass percentage than comprising following composition: bacillus acidophilus 14% ~ 16%, long qi bacillus 13.5% ~ 15.5%, lactobacillus casei 12.5% ~ 14.5%, avette bacillus bifidus 11.8% ~ 13.8%, Lactobacillus Jensenii 11% ~ 13%, Raman lactobacillus 8% ~ 10%, bifidobacterium thermophilum 6.5% ~ 8.5%, sprout short stalk enzyme polysaccharide 1.5% ~ 2.5%, bacillus subtilis enzyme 1.5% ~ 2.5%, lysozyme 1.5% ~ 2.5%, lysozyme beta glucan 1.5% ~ 2.5%, plankton extractions 1.5% ~ 2.5%, Pseudobulbus Bletillae (Rhizoma Bletillae) root extract 1.3% ~ 1.7%, Radix Scutellariae extract 0.8% ~ 1.2%, Herba Centellae extract 1% ~ 1.4%, Radix Glycyrrhizae extract 0.4% ~ 0.6%, Rhizoma Polygoni Cuspidati extract 0.7% ~ 0.9%, Flos Matricariae chamomillae extract 0.3% ~ 0.5%.
2. a kind of active biological enzyme conditioning stock solution according to claim 1, it is characterized in that comprising following composition in mass ratio: bacillus acidophilus 15%, long qi bacillus 14.5%, lactobacillus casei 13.5%, avette bacillus bifidus 12.8%, Lactobacillus Jensenii 12%, Raman lactobacillus 9%, bifidobacterium thermophilum 7.8%, sprout short stalk enzyme polysaccharide 2%, bacillus subtilis enzyme 2%, lysozyme 2%, plankton extractions 2%, Pseudobulbus Bletillae (Rhizoma Bletillae) root extract 1.5%, Radix Scutellariae extract 1%, Herba Centellae extract 1.2%, Radix Glycyrrhizae extract 0.5%, Rhizoma Polygoni Cuspidati extract 0.8%, Flos Matricariae chamomillae extract 0.4%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510942356.1A CN105456178A (en) | 2015-12-16 | 2015-12-16 | Active bio-enzyme conditioning extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510942356.1A CN105456178A (en) | 2015-12-16 | 2015-12-16 | Active bio-enzyme conditioning extract |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105456178A true CN105456178A (en) | 2016-04-06 |
Family
ID=55594648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510942356.1A Pending CN105456178A (en) | 2015-12-16 | 2015-12-16 | Active bio-enzyme conditioning extract |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105456178A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109431924A (en) * | 2018-10-12 | 2019-03-08 | 广东博禧高新科技有限公司 | A kind of anti-inflammatory Essence of aloe maintenance and preparation method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104582712A (en) * | 2012-04-13 | 2015-04-29 | 曼彻斯特大学 | Probiotic bacteria |
CN104856924A (en) * | 2015-05-11 | 2015-08-26 | 湖州品创孵化器有限公司 | External probiotics microcapsule preparation method |
-
2015
- 2015-12-16 CN CN201510942356.1A patent/CN105456178A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104582712A (en) * | 2012-04-13 | 2015-04-29 | 曼彻斯特大学 | Probiotic bacteria |
CN104856924A (en) * | 2015-05-11 | 2015-08-26 | 湖州品创孵化器有限公司 | External probiotics microcapsule preparation method |
Non-Patent Citations (2)
Title |
---|
佚名: ""孝源:和谐篇"", 《"孝源"微信公众号》 * |
佚名: ""祛痘印比祛斑难,远离痘印"", 《"孝源"微信公众号》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109431924A (en) * | 2018-10-12 | 2019-03-08 | 广东博禧高新科技有限公司 | A kind of anti-inflammatory Essence of aloe maintenance and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107922956A (en) | Glycerine derived from staphylococcus epidermis produces accelerating agent, the antimicrobial peptide derived from skin epidermis keratinocyte produces accelerating agent and their applications in skin sparing external preparation | |
Algethami et al. | Bee pollen: Clinical trials and patent applications | |
KR101762594B1 (en) | Composition for curing skin using freshwater cancellous bone grafts and manufacturing method thereof | |
CN102100788A (en) | Chinese medicinal preparation for preventing and treating chicken coccidiosis | |
CN103976914B (en) | A kind of Radix Parthenocissi Heterophyllae extracting solution and its preparation method and application | |
CN109662904A (en) | It is a kind of to have effects that the skin care compositions of whitening antioxidation and its application and preparation method | |
Adlakha et al. | Value-added products of Aloe species: Panacea to several maladies | |
CN106176937A (en) | eczema, acne ointment | |
CN105030620A (en) | Moisturizing and acne removing facial cleanser and preparing method thereof | |
CN104398426A (en) | Mask for treating common acne | |
CN105456178A (en) | Active bio-enzyme conditioning extract | |
CN104623356B (en) | The Chinese medicine for the treatment of helicobacter pylori infections peptic ulcer | |
CN105412415A (en) | Medicine composition removing acnes | |
CN102133161B (en) | Anti-acne and skin-care product | |
CN101628053A (en) | Chinese herbal medicament used to treat painful swollen gum caused by intense stomach fire | |
CN103800785A (en) | Traditional Chinese medicine liniment for external use for treating whelk | |
CN102793838A (en) | Oral traditional Chinese medicament for treating warm-dryness cold | |
CN107822979B (en) | Preparation method of freeze-dried powder of composition with acne removing effect | |
Adom et al. | The chemical constituents, anti-inflammatory, anti-oxidant, and ethnomedicinal properties of aloe barbadensis | |
CN107875059B (en) | Composition with acne removing effect | |
CN105434313B (en) | A kind of Chinese medicine composition with whitening, nti-freckle and crease-resistant effect | |
CN102727804A (en) | Traditional Chinese medicine composition for treating abscess and boil and preparation method thereof | |
CN103656083B (en) | A kind of Chinese medicine composition for the treatment of costal chondritis | |
CN102895471B (en) | Medicine for treatment of acne, folliculitis and pustular herpes and preparation method thereof | |
CN117243863A (en) | Acne-removing composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160406 |